L. Grinfeld

发表

Weight changes after hospitalization for worsening heart failure and subsequent re-hospitalization and mortality in the EVEREST trial.

K. Swedberg, M. Gheorghiade, F. Zannad, 2009, European heart journal.

Clinical course of patients with hyponatremia and decompensated systolic heart failure and the effect of vasopressin receptor antagonism with tolvaptan.

K. Swedberg, M. Gheorghiade, F. Zannad, 2013, Journal of cardiac failure.

Chest Pain in Women: Evaluation and Management

R. Mehran, L. Grinfeld, J. Warren, 2015 .

Facilitated PCI in patients with ST-elevation myocardial infarction.

E. Topol, P. Armstrong, F. Neumann, 2008, The New England journal of medicine.

Electrocardiographic infarct size assessment after thrombolysis: insights from the Acute Myocardial Infarction STudy ADenosine (AMISTAD) trial.

R. Califf, R. Gibbons, C. Granger, 2005, American heart journal.

Revascularization strategies of coronary multiple vessel disease in the Drug Eluting Stent Era: one year follow-up results of the ERACI III Trial.

I. Palacios, Alfredo E. Rodríguez, L. Grinfeld, 2006, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Protection of Distal Embolization in High-Risk Patients with Acute ST-Segment Elevation Myocardial Infarction (PREMIAR).

W. O’Neill, M. Krucoff, M. Trivi, 2007, The American journal of cardiology.

Gender‐based issues in interventional cardiology: A consensus statement from the Women in Innovations (WIN) Initiative

C. Grines, R. Mehran, M. Madan, 2010, Revista espanola de cardiologia.

Gender‐based issues in interventional cardiology: A consensus statement from the Women in Innovations (WIN) Initiative

C. Grines, R. Mehran, M. Madan, 2010, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Gender-based issues in interventional cardiology: a consensus statement from the Women in Innovations (WIN) initiative.

C. Grines, R. Mehran, M. Madan, 2010, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial

Piotr Ponikowski, Gerasimos Filippatos, Elaine Unemori, 2013, The Lancet.

Sex‐based differences in bleeding and long term adverse events after percutaneous coronary intervention for acute myocardial infarction: Three year results from the HORIZONS‐AMI trial

G. Stone, G. Dangas, R. Mehran, 2015, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

SPIRIT Women, evaluation of the safety and efficacy of the XIENCE V everolimus-eluting stent system in female patients: referral time for coronary intervention and 2-year clinical outcomes.

S. Windecker, M. Morice, G. Mikhail, 2012, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Early reperfusion and late clinical outcomes in patients presenting with acute myocardial infarction randomly assigned to primary percutaneous coronary intervention or streptokinase.

Mauricio G. Cohen, L. Grinfeld, P. Oberti, 2003, American heart journal.

Research Article Regional and physician specialty-associated variations in the medical management of atherosclerotic renal-artery stenosis

W. Henrich, D. Cutlip, P. Kalra, 2015 .

Regional and physician specialty-associated variations in the medical management of atherosclerotic renal-artery stenosis.

W. Henrich, D. Cutlip, P. Kalra, 2015, Journal of the American Society of Hypertension : JASH.

International differences in clinical characteristics, management, and outcomes in acute heart failure patients: better short‐term outcomes in patients enrolled in Eastern Europe and Russia in the PROTECT trial

P. Ponikowski, C. O'connor, M. Metra, 2014, European journal of heart failure.

Noncalcified and Calcified Coronary Plaque Detection by Contrast-Enhanced Multi-Detector Computed Tomography: A Study of Interobserver Agreement

I. Palacios, Alfredo E. Rodríguez, L. Grinfeld, 2016 .

Long-term survival in patients with mild or moderate impairment of left ventricular contractility during routine diagnostic left ventriculography.

J. Kramer, M. Goormastic, W. Proudfit, 1998, Catheterization and cardiovascular diagnosis.

Effects of isometric exercise on the diastolic function in patients with severe aortic stenosis with or without coronary lesion.

L. Grinfeld, M. Donato, R. Gelpi, 2005, International journal of cardiology.

Transcutaneous ultrasound-facilitated coronary thrombolysis during acute myocardial infarction.

W. Weaver, Mauricio G. Cohen, R. Siegel, 2003, The American journal of cardiology.

Evaluation of the XIENCE TM V Everolimus-Eluting Coronary Stent System in the Female Latin American Population of the SPIRIT Women Single-Arm Study : One-year Clinical Follow-up Data

P. Lemos, M. Morice, A. Abizaid, 2010 .

Evaluation of the XIENCE™ V Everolimus-Eluting Coronary Stent System in the Female Latin American Population of the SPIRIT Women Single-Arm Study: One-year Clinical Follow-up Data

P. Lemos, M. Morice, A. Abizaid, 2012 .

Application of an Actively Reversible Direct Factor IXa Inhibitor as an Anticoagulation Strategy in Patients Undergoing Percutaneous Coronary Intervention

R. Becker, S. Zelenkofske, Mauricio G. Cohen, 2010 .

Impact of Bleeding and Bivalirudin Therapy on Mortality Risk in Women Undergoing Percutaneous Coronary Intervention (from the REPLACE-2, ACUITY, and HORIZONS-AMI Trials).

G. Stone, A. Baumbach, A. Lincoff, 2016, The American journal of cardiology.

Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials.

K. Swedberg, M. Gheorghiade, F. Zannad, 2007, JAMA.

Polimorfismos plaquetarios (PlA1/A2) y de la óxido nítrico sintetasa (Glu298Asp, -786T>C, 922A/G y el intrónico 420/393) y su relación con la reestenosis intrastent coronario

F. Fuertes, L. Grinfeld, F. Rolandi, 2009 .

Syphilitic aortitis

Mauricio G. Cohen, W. Belloso, L. Grinfeld, 2001, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Syphilitic aortitis. Commentary

T. Cheng, Mauricio G. Cohen, W. Belloso, 2001 .

What is the most effective vascular approach for a diagnostic cardiac catheterization? A randomized trial using the femoral, brachial or radial approaches

L. Grinfeld, D. Berrocal, J. Belardi, 1996 .

Clinical course and predictive value of congestion during hospitalization in patients admitted for worsening signs and symptoms of heart failure with reduced ejection fraction: findings from the EVEREST trial.

K. Swedberg, M. Gheorghiade, F. Zannad, 2013, European heart journal.

Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial.

P. Armstrong, W. Gibler, H. White, 2001 .

Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial.

K. Swedberg, M. Gheorghiade, F. Zannad, 2007, JAMA.

First Clinical Application of an Actively Reversible Direct Factor IXa Inhibitor as an Anticoagulation Strategy in Patients Undergoing Percutaneous Coronary Intervention

R. Becker, S. Zelenkofske, Mauricio G. Cohen, 2010, Circulation.

Interventional Cardiology First Clinical Application of an Actively Reversible Direct Factor IXa Inhibitor as an Anticoagulation Strategy in Patients Undergoing Percutaneous Coronary Intervention

R. Becker, S. Zelenkofske, Mauricio G. Cohen, 2010 .

Effects of tolvaptan on physician-assessed symptoms and signs in patients hospitalized with acute heart failure syndromes: analysis from the efficacy of vasopressin antagonism in heart failure outcome study with tolvaptan (EVEREST) trials.

K. Swedberg, M. Gheorghiade, F. Zannad, 2011, American heart journal.

Lipoprotein‐Associated Phospholipase A2 Activity Is a Marker of Risk But Not a Useful Target for Treatment in Patients With Stable Coronary Heart Disease

P. Pais, Á. Avezum, A. Parkhomenko, 2016, Journal of the American Heart Association.

Darapladib for preventing ischemic events in stable coronary heart disease.

P. Pais, Á. Avezum, A. Parkhomenko, 2014, The New England journal of medicine.

Baseline characteristics of patients in the Reduction of Events with Darbepoetin alfa in Heart Failure trial (RED-HF)

P. Ponikowski, S. Solomon, M. Pfeffer, 2013, European journal of heart failure.

Rationale and design of the multicenter, randomized, double-blind, placebo-controlled study to evaluate the Efficacy of Vasopressin antagonism in Heart Failure: Outcome Study with Tolvaptan (EVEREST).

D. DeMets, K. Swedberg, M. Gheorghiade, 2005, Journal of cardiac failure.

Continental differences in clinical characteristics, management, and outcomes in patients hospitalized with worsening heart failure results from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) program.

K. Swedberg, M. Gheorghiade, F. Zannad, 2008, Journal of the American College of Cardiology.

Clinical implications of QRS duration in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction.

K. Swedberg, M. Gheorghiade, F. Zannad, 2008, JAMA.

Interventions for Cardiovascular Disease in Women

L. Grinfeld, F. Rolandi, 2009, Women's health.

Late loss of early benefit from drug-eluting stents when compared with bare-metal stents and coronary artery bypass surgery: 3 years follow-up of the ERACI III registry.

I. Palacios, A. Maree, Alfredo E. Rodríguez, 2007, European heart journal.

Argentine Randomized Study: Coronary Angioplasty with Stenting versus Coronary Bypass Surgery in patients with Multiple-Vessel Disease (ERACI II): 30-day and one-year follow-up results. ERACI II Investigators.

I. Palacios, W. O’Neill, J. Navia, 2001, Journal of the American College of Cardiology.

Evaluating the safety of very short-term (10 days) dual antiplatelet therapy after Genous™ bio-engineered R stent™ implantation: the multicentre pilot Genous trial.

E. Bramucci, M. Morice, A. Colombo, 2011, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Prognostic value of predischarge electrocardiographic measurement of infarct size after thrombolysis: insights from GUSTO I Economics and Quality of Life substudy.

R. Califf, D. Mark, P. Armstrong, 2004, American heart journal.

Fibrinolytics vs primary angioplasty in acute myocardial infarction (FAP): A randomized trial in a community hospital in Argentina

L. Grinfeld, P. Oberti, A. Cagide, 1996 .

A comprehensive, longitudinal description of the in-hospital and post-discharge clinical, laboratory, and neurohormonal course of patients with heart failure who die or are re-hospitalized within 90 days: analysis from the EVEREST trial

G. Filippatos, K. Swedberg, M. Gheorghiade, 2012, Heart Failure Reviews.

Changes in renal function during hospitalization and soon after discharge in patients admitted for worsening heart failure in the placebo group of the EVEREST trial.

K. Swedberg, M. Gheorghiade, M. Metra, 2011, European heart journal.

Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program: correlation with outcomes.

P. Ponikowski, G. Filippatos, G. Felker, 2013, Journal of the American College of Cardiology.

Short-term Clinical Effects of Tolvaptan, an Oral Vasopressin Antagonist, in Patients Hospitalized for Heart Failure

K. Swedberg, M. Gheorghiade, F. Zannad, 2007 .

Tolvaptan Administration Does Not Affect Steady State Amiodarone Concentrations in Patients With Cardiac Arrhythmias

S. Shoaf, C. Orlandi, L. Grinfeld, 2005, Journal of cardiovascular pharmacology and therapeutics.

A randomized multicenter trial comparing the XIENCE everolimus eluting stent with the CYPHER sirolimus eluting stent in the treatment of female patients with de novo coronary artery lesions: The SPIRIT WOMEN study

Peter Jüni, Stephan Windecker, Raffaele Piccolo, 2017, PloS one.

Efficacy of oral tolvaptan in acute heart failure patients with hypotension and renal impairment

K. Swedberg, M. Vaduganathan, M. Gheorghiade, 2012, Journal of cardiovascular medicine.

Effects of tolvaptan on dyspnoea relief from the EVEREST trials.

Christopher Zimmer, Karl Swedberg, Faiez Zannad, 2009, European heart journal.

Comparative effectiveness at five years of drug-eluting stents, bare metal stents, and coronary bypass surgery: the ERACI III study

M. Hlatky, Alfredo E. Rodríguez, D. Boothroyd, 2012 .

A simple prediction rule for significant renal artery stenosis in patients undergoing cardiac catheterization.

Mauricio G. Cohen, G. Stouffer, L. Grinfeld, 2005, American heart journal.

Imaging and Diagnostic Testing A simple prediction rule for significant renal artery stenosis in patients undergoing cardiac catheterization

Mauricio G. Cohen, G. Stouffer, L. Grinfeld, 2005 .

Implantable Cardioverter-Defibrillators in Patients Hospitalized for Heart Failure With Chronically Reduced Left Ventricular Ejection Fraction

C. O'connor, J. Piccini, K. Swedberg, 2010, American journal of therapeutics.

Coronary stent thrombosis in the current drug-eluting stent era: insights from the ERACI III trial.

I. Palacios, Alfredo E. Rodríguez, L. Grinfeld, 2006, Journal of the American College of Cardiology.

The correlation between presenting ST-segment depression and the final size of acute myocardial infarcts in patients with acute coronary syndromes.

O. Pahlm, R. Selvester, G. Wagner, 2000, Journal of electrocardiology.

The occupational effects of interventional cardiology: results from the WIN for Safety survey.

J. Mehilli, R. Mehran, M. Morice, 2012, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Overview of acute decompensated heart failure in Argentina: lessons learned from 5 registries during the last decade.

A. Barbagelata, L. Grinfeld, E. Perna, 2006, American heart journal.

Irinotecan‐eluting stents inhibited neointimal proliferation in hypercholesterolemic rabbit aortas

L. Grinfeld, G. González, C. Morales, 2006, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Outcome of Hispanic patients treated with thrombolytic therapy for acute myocardial infarction: results from the GUSTO-I and III trials. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries.

R. Califf, E. Topol, E. Ohman, 1999, Journal of the American College of Cardiology.

Women Survey on Women Awareness of Heart Disease

L. Grinfeld, L. Kazelián, M. C. Bruna, 2013 .

Use of drug-eluting stents for the treatment of in-stent restenosis in routine clinical practice

L. Grinfeld, P. Baliño, F. Cura, 2005, Coronary artery disease.

Effects of overexpansion on stents' recoil, symmetry/asymmetry, and neointimal hyperplasia in aortas of hypercholesterolemic rabbits.